AC
NASDAQ · ACRV
Acrivon Therapeutics, Inc. Common Stock
Healthcare · Biotechnology
$2.21
Up+$0.01 (+0.45%)
Updated Aug 23, 2026, 1:50 AM
SID Score
6.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 47.65M
- P/E ratio
- -0.71
- Dividend yield
- 0.00%
- 52-week range
- $1.27 – $2.39
- Volume
- 361.33K
- Avg. volume
- 1.62M
Price performance
ACRV price history
1M range · 20 trading sessions · Daily adjusted prices
ACRV closed at $2.21 after 20 trading sessions, up 41.67% for the selected period.
- Last close
- $2.21
- Period change
- +41.67%
- Period low
- $1.43
- Period high
- $2.39
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $2.21 | $2.31 | $2.18 | $2.21 | 361.33K |
| Aug 20, 2026 | $2.33 | $2.37 | $2.17 | $2.20 | 499.43K |
| Aug 19, 2026 | $2.06 | $2.39 | $2.06 | $2.39 | 731.49K |
| Aug 18, 2026 | $2.05 | $2.065 | $1.97 | $2.05 | 336.37K |
| Aug 17, 2026 | $2.11 | $2.14 | $1.96 | $2.05 | 1.5M |
| Aug 14, 2026 | $1.90 | $1.99 | $1.85 | $1.95 | 758.08K |
| Aug 13, 2026 | $1.73 | $1.90 | $1.7037 | $1.85 | 422.31K |
| Aug 12, 2026 | $1.75 | $1.75 | $1.70 | $1.72 | 152.06K |
| Aug 11, 2026 | $1.78 | $1.78 | $1.69 | $1.73 | 164.45K |
| Aug 10, 2026 | $1.77 | $1.78 | $1.73 | $1.74 | 228.9K |
| Aug 7, 2026 | $1.73 | $1.7599 | $1.71 | $1.73 | 302.25K |
| Aug 6, 2026 | $1.62 | $1.69 | $1.6018 | $1.69 | 316.17K |
| Aug 5, 2026 | $1.61 | $1.65 | $1.59 | $1.64 | 318.81K |
| Aug 4, 2026 | $1.57 | $1.61 | $1.555 | $1.56 | 184.3K |
| Aug 3, 2026 | $1.52 | $1.58 | $1.482 | $1.56 | 242.03K |
| Jul 31, 2026 | $1.57 | $1.64 | $1.50 | $1.50 | 506.28K |
| Jul 30, 2026 | $1.43 | $1.54 | $1.41 | $1.52 | 388.44K |
| Jul 29, 2026 | $1.50 | $1.5692 | $1.41 | $1.43 | 774.05K |
| Jul 28, 2026 | $1.55 | $1.61 | $1.51 | $1.54 | 235.43K |
| Jul 27, 2026 | $1.62 | $1.62 | $1.5511 | $1.56 | 150.11K |
Latest ACRV news
The latest Smart Investors Daily articles mentioning ACRV.
Stock researchCompany · Financials
Loading stock research…
